
Dux Ducis Pharmaceuticals Private Limited
Pharmaceutical company trading medicine, tablets, capsules, and antibiotics.
Pharmaceutical company trading medicine, tablets, capsules, and antibiotics.
Dux Ducis Pharmaceuticals Private Limited (DDPPL) is a Private Limited Indian Non-Government Company incorporated in India on 12 March 2014 and has a history of 11 years and two months. Its registered office is in Thane, Maharashtra, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2019. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹1.88 M.
Vaibhav Giri, Anuradha Giri, Prashant Pakhidde, and Three other members serve as directors at the Company.
Thane, Maharashtra, India
+91-XXXXXXXXXX
U51101MH2014PTC254173
254173
Private Limited Indian Non-Government Company
12 Mar 2014
30 Sep 2019
31 Mar 2019
Unlisted
Roc Mumbai
Name | Designation | Appointment Date | Status |
---|---|---|---|
Vaibhav Giri ![]() | Director | 12-Mar-2014 | Current |
Anuradha Giri ![]() | Director | 10-Dec-2014 | Current |
Prashant Pakhidde ![]() | Additional Director | 18-Sep-2017 | Current |
Vivekanand Manwatkar ![]() | Additional Director | 18-Sep-2017 | Current |
Vaibhav Pande ![]() | Additional Director | 15-Dec-2018 | Current |
Yogesh Kanchalwar ![]() | Additional Director | 15-Dec-2018 | Current |
Dux Ducis Pharmaceuticals Private Limited, for the financial year ended 2019, experienced significant reduction in revenue, with a 55.8% decrease. The company also saw a substantial fall in profitability, with a 851.09% decrease in profit. The company's net worth observed a substantial decline by a decrease of 77.17%.
Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
| ||||||
Revenue from Operations |
| ||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
In 2019, Dux Ducis Pharmaceuticals had a promoter holding of 50.00% and a public holding of 50.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
₹1.88 M
₹0
Date | Lender | Amount | Status |
---|---|---|---|
31 Jul 2015 | Punjab National Bank | ₹1.88 M | Open |
Unlock and access historical data on people associated with Dux Ducis Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Dux Ducis Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Dux Ducis Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Dux Ducis Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2019 as per latest MCA records.
Dux Ducis Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2019 with Roc Mumbai.
Vaibhav Himatrao Pande was appointed as a Additional Director was appointed as a Additional Director on 15 Dec 2018 & has been associated with this company since 6 years 5 months .
Yogesh Subhash Kanchalwar was appointed as a Additional Director was appointed as a Additional Director on 15 Dec 2018 & has been associated with this company since 6 years 5 months .
Prashant Rupchand Pakhidde was appointed as a Additional Director was appointed as a Additional Director on 18 Sep 2017 & has been associated with this company since 7 years 8 months .
Vivekanand Sudhakar Manwatkar was appointed as a Additional Director was appointed as a Additional Director on 18 Sep 2017 & has been associated with this company since 7 years 8 months .
Dux Ducis Pharmaceuticals Private Limited was incorporated on 12 Mar 2014.
The authorized share capital of Dux Ducis Pharmaceuticals Private Limited is ₹ 0.10 M and paid-up capital is ₹ 0.10 M.
Currently 6 directors are associated with Dux Ducis Pharmaceuticals Private Limited.
As per Ministry of Corporate Affairs (Mca), the registered address of Dux Ducis Pharmaceuticals Private Limited is Shop No. 3 Beach View Apt Palm Road Sector 6, Nerul India, Navi Mumbai, Maharashtra, 400706.
The corporate identification number (CIN) of Dux Ducis Pharmaceuticals Private Limited is U51101MH2014PTC254173 and the company number is 254173 as per Ministry of Corporate Affairs (MCA).
According to the financial reports for the fiscal year 2019, the revenue trend for Dux Ducis Pharmaceuticals Private Limited has fallen by -55.80%.
The financial reports for the fiscal year 2019 indicates that The net worth of Dux Ducis Pharmaceuticals Private Limited has experienced an downturn of -77.17%.
As per the financial statements for fiscal Year 2019, The total open charges for Dux Ducis Pharmaceuticals Private Limited amount to ₹ 1.88 M.
The most recent Balance Sheet for Dux Ducis Pharmaceuticals Private Limited was filed with the ROC on 31 Mar 2019.
Search company & director profiles for free and gain access to critical business data.
NI